Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

2.

The deactivation of implantable cardioverter-defibrillators: medical, ethical, practical, and legal considerations.

Carlsson J, Paul NW, Dann M, Neuzner J, Pfeiffer D.

Dtsch Arztebl Int. 2012 Aug;109(33-34):535-41. doi: 10.3238/arztebl.2012.0535. Epub 2012 Aug 20. Review.

3.

Ethical and legal views regarding deactivation of cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy.

Kramer DB, Kesselheim AS, Salberg L, Brock DW, Maisel WH.

Am J Cardiol. 2011 Apr 1;107(7):1071-1075.e5. doi: 10.1016/j.amjcard.2010.11.036. Epub 2011 Feb 4.

4.

Ethical and legal perspective of implantable cardioverter defibrillator deactivation or implantable cardioverter defibrillator generator replacement in the elderly.

Wright GA, Klein GJ, Gula LJ.

Curr Opin Cardiol. 2013 Jan;28(1):43-9. doi: 10.1097/HCO.0b013e32835b0b3b. Review.

PMID:
23128499
5.

Deactivation of pacemakers and implantable cardioverter-defibrillators.

Kramer DB, Mitchell SL, Brock DW.

Prog Cardiovasc Dis. 2012 Nov-Dec;55(3):290-9. doi: 10.1016/j.pcad.2012.09.003. Review.

6.

Deactivation of implanted cardioverter-defibrillators at the end of life: results of the EHRA survey.

Marinskis G, van Erven L; EHRA Scientific Initiatives Committee.

Europace. 2010 Aug;12(8):1176-7. doi: 10.1093/europace/euq272.

PMID:
20663788
8.

Within you/without you: biotechnology, ontology, and ethics.

Sulmasy DP.

J Gen Intern Med. 2008 Jan;23 Suppl 1:69-72. doi: 10.1007/s11606-007-0326-x. Review.

9.

[Implantable cardioverter-defibrillator deactivation at the end of life: ethical, clinical and communication issues].

RomanĂ² M, Piga MA, Bertona R, Negro R, Ruggeri C, Zorzoli F, Villani R.

G Ital Cardiol (Rome). 2017 Feb;18(2):139-149. doi: 10.1714/2663.27299. Review. Italian.

PMID:
28398367
10.

EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy.

Padeletti L, Arnar DO, Boncinelli L, Brachman J, Camm JA, Daubert JC, Hassam SK, Deliens L, Glikson M, Hayes D, Israel C, Lampert R, Lobban T, Raatikainen P, Siegal G, Vardas P; Reviewers:, Kirchhof P, Becker R, Cosio F, Loh P, Cobbe S, Grace A, Morgan J; EuropeanHeart RhythmAssociation; Heart Rhythm Society.

Europace. 2010 Oct;12(10):1480-9. doi: 10.1093/europace/euq275. Epub 2010 Jul 30. Erratum in: Europace. 2011 Apr;13(4):599. Kassam, Sarah [corrected to Hassam, Sarah K].

PMID:
20675674
11.

Original research: deactivation of ICDs at the end of life: a systematic review of clinical practices and provider and patient attitudes.

Russo JE.

Am J Nurs. 2011 Oct;111(10):26-35. doi: 10.1097/01.NAJ.0000406411.49438.91. Review.

PMID:
21926561
12.

[Deactivation of implantable defibrillators--also an ethical issue. Written routines of the process are necessary as illustrated by the described case report].

Carlsson J, Mansson A, Olsson D.

Lakartidningen. 2011 Mar 9-15;108(10):536-9. Swedish. No abstract available.

PMID:
21744554
13.

Deactivating cardiac pacemakers and implantable cardioverter defibrillators in terminally ill patients.

Beca JP, Rosselot E, Asenjo R, Anguita V, Quevedo R.

Camb Q Healthc Ethics. 2009 Summer;18(3):236-40. doi: 10.1017/S0963180109090380. No abstract available.

PMID:
19460224
14.
15.

Ethical challenges of deactivation of cardiac devices in advanced heart failure.

Chamsi-Pasha H, Chamsi-Pasha MA, Albar MA.

Curr Heart Fail Rep. 2014 Jun;11(2):119-25. doi: 10.1007/s11897-014-0194-8. Review.

PMID:
24619521
16.

The ethics of deactivating implanted cardioverter defibrillators.

Berger JT.

Ann Intern Med. 2005 Apr 19;142(8):631-4.

PMID:
15838070
17.

Should implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness be deactivated? Deactivating permanent pacemaker in patients with terminalillness. Patient autonomy is paramount.

Zellner RA, Aulisio MP, Lewis WR.

Circ Arrhythm Electrophysiol. 2009 Jun;2(3):340-4; discussion 340. doi: 10.1161/CIRCEP.109.848523. No abstract available.

18.

Considerations in Patients With Cardiac Implantable Electronic Devices at End of Life.

Gura MT.

AACN Adv Crit Care. 2015 Oct-Dec;26(4):356-63. doi: 10.1097/NCI.0000000000000111. Review.

PMID:
26484996
19.

Ethical considerations for discontinuing pacemakers and automatic implantable cardiac defibrillators at the end-of-life.

Morgenweck CJ.

Curr Opin Anaesthesiol. 2013 Apr;26(2):171-5. doi: 10.1097/ACO.0b013e32835e8349. Review.

PMID:
23403711
20.

[Deactivating pacemakers in terminally ill patients].

Hotvedt R.

Tidsskr Nor Laegeforen. 2008 Aug 14;128(15):1680. Norwegian. No abstract available.

Supplemental Content

Support Center